JIE Guang-ling, FU Rui, DONG Song. Neoadjuvant Targeted Therapy for a Stage ⅢB Non-Small Cell Lung Cancer With ROS1 Rearrangements[J]. Journal of Evidence-Based Medicine, 2022, 22(2): 126-128. DOI: 10.12019/j.issn.1671-5144.2022.02.010
|
Citation:
|
JIE Guang-ling, FU Rui, DONG Song. Neoadjuvant Targeted Therapy for a Stage ⅢB Non-Small Cell Lung Cancer With ROS1 Rearrangements[J]. Journal of Evidence-Based Medicine, 2022, 22(2): 126-128. DOI: 10.12019/j.issn.1671-5144.2022.02.010
|
JIE Guang-ling, FU Rui, DONG Song. Neoadjuvant Targeted Therapy for a Stage ⅢB Non-Small Cell Lung Cancer With ROS1 Rearrangements[J]. Journal of Evidence-Based Medicine, 2022, 22(2): 126-128. DOI: 10.12019/j.issn.1671-5144.2022.02.010
|
Citation:
|
JIE Guang-ling, FU Rui, DONG Song. Neoadjuvant Targeted Therapy for a Stage ⅢB Non-Small Cell Lung Cancer With ROS1 Rearrangements[J]. Journal of Evidence-Based Medicine, 2022, 22(2): 126-128. DOI: 10.12019/j.issn.1671-5144.2022.02.010
|
DownLoad: